Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0638-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0637-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0636-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0635-2026Class IIOngoingJun 24, 2026Cura HongosCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0634-2026Class IIOngoingJun 24, 2026Rapidol, Triple Antibiotic First Aid OintmentCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0633-2026Class IIOngoingJun 24, 2026Lil Drug StoreCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0632-2026Class IIOngoingJun 24, 2026Circle KCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0631-2026Class IIOngoingJun 24, 2026Lucky Super SoftCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0630-2026Class IIOngoingJun 24, 2026Lucky Super SoftCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0629-2026Class IIOngoingJun 24, 2026Chlorthalidone TabletsFailed Dissolution SpecificationsInventia Healthcare Limited · D-0610-2026Class IIIOngoingJun 24, 2026Focalin XRLabeling: Incorrect or Missing Lot and/or Exp DateSandoz Inc · D-0608-2026Class IIOngoingJun 24, 2026safco SensiCaine-UltraDefective container:may contain bottles with incomplete sealsKeystone Industries · D-0606-2026Class IIOngoingJun 24, 2026PureLifeDefective container:may contain bottles with incomplete sealsKeystone Industries · D-0605-2026Class IIOngoingJun 24, 2026Dental City TOPICAL ANESTHETIC GELDefective container:may contain bottles with incomplete sealsKeystone Industries · D-0604-2026Class IIOngoingJun 24, 2026Burkhart topical anesthetic gelDefective container:may contain bottles with incomplete sealsKeystone Industries · D-0603-2026Class IIOngoingJun 24, 2026DHP Topical Anesthetic GelDefective container:may contain bottles with incomplete sealsKeystone Industries · D-0602-2026Class IIOngoingJun 24, 2026Quala Dental ProductsDefective container:may contain bottles with incomplete sealsKeystone Industries · D-0601-2026Class IIOngoingJun 24, 2026Pearson Quality Topical Anesthetic GelDefective container:may contain bottles with incomplete sealsKeystone Industries · D-0600-2026Class IIOngoingJun 24, 2026Buprenorphine HClCrystallization; identified as Buprenorphine free basePar Health USA, LLC · D-0596-2026Class IIOngoingJun 24, 2026Aripiprazole Tablets USPProduct Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.Ajanta Pharma USA Inc · D-0594-2026Class IIOngoingJun 24, 2026Vasopressin 2 Units/2 mL in 0.9% Sodium ChlorideSubpotent DrugIntegraDose Compounding Services LLC · D-0593-2026Class IIOngoingJun 24, 2026VistaPharmDoes Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023PAI Holdings LLC · D-0592-2026Class IIOngoingJun 24, 2026VistaPharmDoes Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023PAI Holdings LLC · D-0591-2026Class IIOngoingJun 24, 2026VistaPharmDoes Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023PAI Holdings LLC · D-0590-2026Class IIOngoingJun 24, 2026VistaPharmDoes Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023PAI Holdings LLC · D-0589-2026Class IIOngoingJun 24, 2026Alyacen 7/7/7Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.Glenmark Pharmaceuticals Inc., USA · D-0588-2026Class IOngoingJun 17, 2026BEEKEEPER'S NATURALS Saline Nasal SprayMicrobial Contamination of Non-Sterile ProductsBeekeeper's Naturals USA Inc. · D-0620-2026Class IIOngoingJun 17, 2026Budesonide Inhalation SuspensionPresence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule...Sun Pharmaceutical Industries Inc · D-0607-2026Class IIOngoingJun 17, 2026Minocycline Hydrochloride Extended-Release TabletsFailed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysisAscend Laboratories, LLC · D-0597-2026Class IOngoingJun 17, 2026Gas-X Extra StrengthChemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process.Haleon US Holdings LLC · D-0595-2026Class IIOngoingJun 17, 2026GSMS IncorporatedFailed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour...Golden State Medical Supply Inc. · D-0587-2026Class IIOngoingJun 17, 2026Zep, Alcohol Sanitizer SprayMicrobial contamination of sterile productsZep Inc · D-0586-2026Class IIIOngoingJun 17, 2026Primidone TabletsCross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.Amneal Pharmaceuticals, LLC · D-0585-2026Class IIOngoingJun 17, 2026Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limitBreckenridge Pharmaceutical, Inc. · D-0583-2026Class IIOngoingJun 17, 2026Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limitBreckenridge Pharmaceutical, Inc. · D-0582-2026Class IIIOngoingJun 17, 2026Epinephrine InjectionFailed Impurities/Degradations SpecificationsFresenius Kabi USA, LLC · D-0581-2026Class IOngoingJun 17, 2026DOXOrubin Hydrochloride Liposome injectionPresence of Particulate matter: Particulate matter identified as glass.Sun Pharmaceutical Industries Inc · D-0580-2026Class IIOngoingJun 10, 2026Xyvona (levorphanol tartrate tablets)Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name XyvonaSun Pharmaceutical Industries Inc · D-0599-2026Class IIOngoingJun 10, 2026Xyvona (levorphanol tartrate tablets)Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name XyvonaSun Pharmaceutical Industries Inc · D-0598-2026

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.